Park SY, Suh KJ, Lee DW, Ryu HS, et al. Prognostic role of tumor subtype and germline BRCA mutation in advanced breast cancer patients treated with palbociclib plus endocrine therapy. Breast Cancer Res Treat 2022 Sep 7. pii: 10.1007/s10549-022-06566.
PMID: 36070058